UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Effect of food on the pharmacokinetics of multiple‐dose oral voriconazole

British journal of clinical pharmacology, 2003-12, Vol.56 (s1), p.17-23

2003

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safety

British journal of clinical pharmacology, 2003-12, Vol.56 (s1), p.10-16

2003

Link zum Volltext

Verfügbarkeit prüfen

Effect of omeprazole on the steady‐state pharmacokinetics of voriconazole

British journal of clinical pharmacology, 2003-12, Vol.56 (s1), p.56-61

2003

Link zum Volltext

Verfügbarkeit prüfen

Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration

British journal of clinical pharmacology, 2003-12, Vol.56 (s1), p.37-44

2003

Link zum Volltext

Verfügbarkeit prüfen

The pharmacokinetics and safety of intravenous voriconazole – a novel wide‐spectrum antifungal agent

British journal of clinical pharmacology, 2003-12, Vol.56 (s1), p.2-9

2003

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole potentiates warfarin‐induced prothrombin time prolongation

British journal of clinical pharmacology, 2003-12, Vol.56 (s1), p.24-29

2003

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the histamine H 4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis

Journal of allergy and clinical immunology, 2019-05, Vol.143 (5), p.1830

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis

Journal of allergy and clinical immunology, 2019-05, Vol.143 (5), p.1830-1837.e4

2019

Link zum Volltext

Verfügbarkeit prüfen

Histamine H2‐receptor antagonists have no clinically significant effect on the steady‐state pharmacokinetics of voriconazole

British journal of clinical pharmacology, 2003-12, Vol.56 (Suppl 1), p.51-55

2003

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole does not affect the steady‐state pharmacokinetics of digoxin

British journal of clinical pharmacology, 2003-12, Vol.56 (s1), p.45-50

2003

Link zum Volltext

Verfügbarkeit prüfen

Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigms

Xenobiotica, 2012-01, Vol.42 (1), p.57-74

2012

Link zum Volltext

Verfügbarkeit prüfen

No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers

British journal of clinical pharmacology, 2003-12, Vol.56 (s1), p.62-68

2003

Link zum Volltext

Verfügbarkeit prüfen

No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers

British journal of clinical pharmacology, 2003-12, Vol.56 (s1), p.30-36

2003

Link zum Volltext

Verfügbarkeit prüfen

Histamine H 2 ‐receptor antagonists have no clinically significant effect on the steady‐state pharmacokinetics of voriconazole

British journal of clinical pharmacology, 2003-12, Vol.56 (s1), p.51-55

2003

Link zum Volltext

Verfügbarkeit prüfen

A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers

The American journal of surgery, 1998-12, Vol.176 (6), p.27S-31S

1998

Link zum Volltext

Verfügbarkeit prüfen

Pre- and postnatal development of adipose tissue at four sites in the guinea pig: effect of maternal diet restriction during the second half of pregnancy

Annals of nutrition and metabolism, 1987, Vol.31 (4), p.197

1987

Link zum Volltext

Verfügbarkeit prüfen

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)
Japanisch
(6)

Erscheinungsjahr

n.n

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of food on the pharmacokinetics of multiple‐dose oral voriconazole

Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safety

Effect of omeprazole on the steady‐state pharmacokinetics of voriconazole

Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration

The pharmacokinetics and safety of intravenous voriconazole – a novel wide‐spectrum antifungal agent

Voriconazole potentiates warfarin‐induced prothrombin time prolongation

Efficacy and safety of the histamine H 4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis

Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis

Histamine H2‐receptor antagonists have no clinically significant effect on the steady‐state pharmacokinetics of voriconazole

Voriconazole does not affect the steady‐state pharmacokinetics of digoxin

Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigms

No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers

No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers

Histamine H 2 ‐receptor antagonists have no clinically significant effect on the steady‐state pharmacokinetics of voriconazole

A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers

Pre- and postnatal development of adipose tissue at four sites in the guinea pig: effect of maternal diet restriction during the second half of pregnancy

Suchergebnisse filtern